Individualized correction of insulin measurement in hemolyzed serum samples

Insulin measurement plays a key role in the investigation of patients with hypoglycemia, subtype classification of diabetes mellitus, insulin resistance, and impaired beta cell function. However, even slight hemolysis can negatively affect insulin measurement due to RBC insulin-degrading enzyme (IDE...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunologic research 2017-06, Vol.65 (3), p.605-608
Hauptverfasser: Wu, Zhi-Qi, Lu, Ju, Chen, Huanhuan, Chen, Wensen, Xu, Hua-Guo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 608
container_issue 3
container_start_page 605
container_title Immunologic research
container_volume 65
creator Wu, Zhi-Qi
Lu, Ju
Chen, Huanhuan
Chen, Wensen
Xu, Hua-Guo
description Insulin measurement plays a key role in the investigation of patients with hypoglycemia, subtype classification of diabetes mellitus, insulin resistance, and impaired beta cell function. However, even slight hemolysis can negatively affect insulin measurement due to RBC insulin-degrading enzyme (IDE). Here, we derived and validated an individualized correction equation in an attempt to eliminate the effects of hemolysis on insulin measurement. The effects of hemolysis on insulin measurement were studied by adding lysed self-RBCs to serum. A correction equation was derived, accounting for both percentage and exposure time of hemolysis. The performance of this individualized correction was evaluated in intentionally hemolyzed samples. Insulin concentration decreased with increasing percentage and exposure time of hemolysis. Based on the effects of hemolysis on insulin measurement of 17 donors (baseline insulin concentrations ranged from 156 to 2119 pmol/L), the individualized hemolysis correction equation was derived: INS corr  = INS meas /(0.705lgHb plasma /Hb serum  − 0.001Time − 0.612). This equation can revert insulin concentrations of the intentionally hemolyzed samples to values that were statistically not different from the corresponding insulin baseline concentrations ( p  = 0.1564). Hemolysis could lead to a negative interference on insulin measurement; by individualized hemolysis correction equation for insulin measurement, we can correct and report reliable serum insulin results for a wide range of degrees of sample hemolysis. This correction would increase diagnostic accuracy, reduce inappropriate therapeutic decisions, and improve patient satisfaction with care.
doi_str_mv 10.1007/s12026-016-8878-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837025584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1901185392</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-2fd70674a5377737036286873e4ff51e62bd1c48c8ee838431f35ef4ba3d551e3</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMotlYfwI0MuHETzWUyJ7OU4qVYcKPgLqQzJzplLjXpCPXpTZkqIrg6kPP9_wkfIaecXXLG4CpwwURGGc-o1qAp7JExVyqnDJTaJ2MmFFAB8DIiRyEsWQTTVB6SkQDNgaf5mDzM2rL6qMre1tUnlknReY_FuurapHNJ1Ya-rtqkQRt6jw226_iWvGHT1ZstHtD3TRJss6oxHJMDZ-uAJ7s5Ic-3N0_Tezp_vJtNr-e0kCDWVLgSWAapVRIAJDCZCZ1pkJg6pzhmYlHyItWFRtRSp5I7qdClCytLFfdyQi6G3pXv3nsMa9NUocC6ti12fTBcx1KhVIxOyPkfdNn1vo2_MzxnnGslcxEpPlCF70Lw6MzKV431G8OZ2Zo2g2kTBZqtaQMxc7Zr7hcNlj-Jb7UREAMQ4qp9Rf_r9L-tX5YdiHU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901185392</pqid></control><display><type>article</type><title>Individualized correction of insulin measurement in hemolyzed serum samples</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wu, Zhi-Qi ; Lu, Ju ; Chen, Huanhuan ; Chen, Wensen ; Xu, Hua-Guo</creator><creatorcontrib>Wu, Zhi-Qi ; Lu, Ju ; Chen, Huanhuan ; Chen, Wensen ; Xu, Hua-Guo</creatorcontrib><description>Insulin measurement plays a key role in the investigation of patients with hypoglycemia, subtype classification of diabetes mellitus, insulin resistance, and impaired beta cell function. However, even slight hemolysis can negatively affect insulin measurement due to RBC insulin-degrading enzyme (IDE). Here, we derived and validated an individualized correction equation in an attempt to eliminate the effects of hemolysis on insulin measurement. The effects of hemolysis on insulin measurement were studied by adding lysed self-RBCs to serum. A correction equation was derived, accounting for both percentage and exposure time of hemolysis. The performance of this individualized correction was evaluated in intentionally hemolyzed samples. Insulin concentration decreased with increasing percentage and exposure time of hemolysis. Based on the effects of hemolysis on insulin measurement of 17 donors (baseline insulin concentrations ranged from 156 to 2119 pmol/L), the individualized hemolysis correction equation was derived: INS corr  = INS meas /(0.705lgHb plasma /Hb serum  − 0.001Time − 0.612). This equation can revert insulin concentrations of the intentionally hemolyzed samples to values that were statistically not different from the corresponding insulin baseline concentrations ( p  = 0.1564). Hemolysis could lead to a negative interference on insulin measurement; by individualized hemolysis correction equation for insulin measurement, we can correct and report reliable serum insulin results for a wide range of degrees of sample hemolysis. This correction would increase diagnostic accuracy, reduce inappropriate therapeutic decisions, and improve patient satisfaction with care.</description><identifier>ISSN: 0257-277X</identifier><identifier>EISSN: 1559-0755</identifier><identifier>DOI: 10.1007/s12026-016-8878-7</identifier><identifier>PMID: 27817149</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Allergology ; Beta cells ; Biomedical and Life Sciences ; Biomedicine ; Diabetes mellitus ; Diabetes Mellitus - diagnosis ; Diagnostic Errors - prevention &amp; control ; Diagnostic systems ; Erythrocytes - metabolism ; Erythrocytes - pathology ; Exposure ; Hemolysis ; Humans ; Hypoglycemia ; Hypoglycemia - diagnosis ; Immunology ; Insulin ; Insulin - blood ; Insulin resistance ; Insulysin ; Insulysin - metabolism ; Internal Medicine ; Medicine/Public Health ; Models, Theoretical ; Original Article ; Precision Medicine ; Reproducibility of Results ; Serum - metabolism ; Statistical analysis ; Statistical methods</subject><ispartof>Immunologic research, 2017-06, Vol.65 (3), p.605-608</ispartof><rights>Springer Science+Business Media New York 2016</rights><rights>Immunologic Research is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-2fd70674a5377737036286873e4ff51e62bd1c48c8ee838431f35ef4ba3d551e3</citedby><cites>FETCH-LOGICAL-c372t-2fd70674a5377737036286873e4ff51e62bd1c48c8ee838431f35ef4ba3d551e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12026-016-8878-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12026-016-8878-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27817149$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Zhi-Qi</creatorcontrib><creatorcontrib>Lu, Ju</creatorcontrib><creatorcontrib>Chen, Huanhuan</creatorcontrib><creatorcontrib>Chen, Wensen</creatorcontrib><creatorcontrib>Xu, Hua-Guo</creatorcontrib><title>Individualized correction of insulin measurement in hemolyzed serum samples</title><title>Immunologic research</title><addtitle>Immunol Res</addtitle><addtitle>Immunol Res</addtitle><description>Insulin measurement plays a key role in the investigation of patients with hypoglycemia, subtype classification of diabetes mellitus, insulin resistance, and impaired beta cell function. However, even slight hemolysis can negatively affect insulin measurement due to RBC insulin-degrading enzyme (IDE). Here, we derived and validated an individualized correction equation in an attempt to eliminate the effects of hemolysis on insulin measurement. The effects of hemolysis on insulin measurement were studied by adding lysed self-RBCs to serum. A correction equation was derived, accounting for both percentage and exposure time of hemolysis. The performance of this individualized correction was evaluated in intentionally hemolyzed samples. Insulin concentration decreased with increasing percentage and exposure time of hemolysis. Based on the effects of hemolysis on insulin measurement of 17 donors (baseline insulin concentrations ranged from 156 to 2119 pmol/L), the individualized hemolysis correction equation was derived: INS corr  = INS meas /(0.705lgHb plasma /Hb serum  − 0.001Time − 0.612). This equation can revert insulin concentrations of the intentionally hemolyzed samples to values that were statistically not different from the corresponding insulin baseline concentrations ( p  = 0.1564). Hemolysis could lead to a negative interference on insulin measurement; by individualized hemolysis correction equation for insulin measurement, we can correct and report reliable serum insulin results for a wide range of degrees of sample hemolysis. This correction would increase diagnostic accuracy, reduce inappropriate therapeutic decisions, and improve patient satisfaction with care.</description><subject>Allergology</subject><subject>Beta cells</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - diagnosis</subject><subject>Diagnostic Errors - prevention &amp; control</subject><subject>Diagnostic systems</subject><subject>Erythrocytes - metabolism</subject><subject>Erythrocytes - pathology</subject><subject>Exposure</subject><subject>Hemolysis</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Hypoglycemia - diagnosis</subject><subject>Immunology</subject><subject>Insulin</subject><subject>Insulin - blood</subject><subject>Insulin resistance</subject><subject>Insulysin</subject><subject>Insulysin - metabolism</subject><subject>Internal Medicine</subject><subject>Medicine/Public Health</subject><subject>Models, Theoretical</subject><subject>Original Article</subject><subject>Precision Medicine</subject><subject>Reproducibility of Results</subject><subject>Serum - metabolism</subject><subject>Statistical analysis</subject><subject>Statistical methods</subject><issn>0257-277X</issn><issn>1559-0755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kMtKAzEUhoMotlYfwI0MuHETzWUyJ7OU4qVYcKPgLqQzJzplLjXpCPXpTZkqIrg6kPP9_wkfIaecXXLG4CpwwURGGc-o1qAp7JExVyqnDJTaJ2MmFFAB8DIiRyEsWQTTVB6SkQDNgaf5mDzM2rL6qMre1tUnlknReY_FuurapHNJ1Ya-rtqkQRt6jw226_iWvGHT1ZstHtD3TRJss6oxHJMDZ-uAJ7s5Ic-3N0_Tezp_vJtNr-e0kCDWVLgSWAapVRIAJDCZCZ1pkJg6pzhmYlHyItWFRtRSp5I7qdClCytLFfdyQi6G3pXv3nsMa9NUocC6ti12fTBcx1KhVIxOyPkfdNn1vo2_MzxnnGslcxEpPlCF70Lw6MzKV431G8OZ2Zo2g2kTBZqtaQMxc7Zr7hcNlj-Jb7UREAMQ4qp9Rf_r9L-tX5YdiHU</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Wu, Zhi-Qi</creator><creator>Lu, Ju</creator><creator>Chen, Huanhuan</creator><creator>Chen, Wensen</creator><creator>Xu, Hua-Guo</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Individualized correction of insulin measurement in hemolyzed serum samples</title><author>Wu, Zhi-Qi ; Lu, Ju ; Chen, Huanhuan ; Chen, Wensen ; Xu, Hua-Guo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-2fd70674a5377737036286873e4ff51e62bd1c48c8ee838431f35ef4ba3d551e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Allergology</topic><topic>Beta cells</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - diagnosis</topic><topic>Diagnostic Errors - prevention &amp; control</topic><topic>Diagnostic systems</topic><topic>Erythrocytes - metabolism</topic><topic>Erythrocytes - pathology</topic><topic>Exposure</topic><topic>Hemolysis</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Hypoglycemia - diagnosis</topic><topic>Immunology</topic><topic>Insulin</topic><topic>Insulin - blood</topic><topic>Insulin resistance</topic><topic>Insulysin</topic><topic>Insulysin - metabolism</topic><topic>Internal Medicine</topic><topic>Medicine/Public Health</topic><topic>Models, Theoretical</topic><topic>Original Article</topic><topic>Precision Medicine</topic><topic>Reproducibility of Results</topic><topic>Serum - metabolism</topic><topic>Statistical analysis</topic><topic>Statistical methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Zhi-Qi</creatorcontrib><creatorcontrib>Lu, Ju</creatorcontrib><creatorcontrib>Chen, Huanhuan</creatorcontrib><creatorcontrib>Chen, Wensen</creatorcontrib><creatorcontrib>Xu, Hua-Guo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Immunologic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Zhi-Qi</au><au>Lu, Ju</au><au>Chen, Huanhuan</au><au>Chen, Wensen</au><au>Xu, Hua-Guo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Individualized correction of insulin measurement in hemolyzed serum samples</atitle><jtitle>Immunologic research</jtitle><stitle>Immunol Res</stitle><addtitle>Immunol Res</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>65</volume><issue>3</issue><spage>605</spage><epage>608</epage><pages>605-608</pages><issn>0257-277X</issn><eissn>1559-0755</eissn><abstract>Insulin measurement plays a key role in the investigation of patients with hypoglycemia, subtype classification of diabetes mellitus, insulin resistance, and impaired beta cell function. However, even slight hemolysis can negatively affect insulin measurement due to RBC insulin-degrading enzyme (IDE). Here, we derived and validated an individualized correction equation in an attempt to eliminate the effects of hemolysis on insulin measurement. The effects of hemolysis on insulin measurement were studied by adding lysed self-RBCs to serum. A correction equation was derived, accounting for both percentage and exposure time of hemolysis. The performance of this individualized correction was evaluated in intentionally hemolyzed samples. Insulin concentration decreased with increasing percentage and exposure time of hemolysis. Based on the effects of hemolysis on insulin measurement of 17 donors (baseline insulin concentrations ranged from 156 to 2119 pmol/L), the individualized hemolysis correction equation was derived: INS corr  = INS meas /(0.705lgHb plasma /Hb serum  − 0.001Time − 0.612). This equation can revert insulin concentrations of the intentionally hemolyzed samples to values that were statistically not different from the corresponding insulin baseline concentrations ( p  = 0.1564). Hemolysis could lead to a negative interference on insulin measurement; by individualized hemolysis correction equation for insulin measurement, we can correct and report reliable serum insulin results for a wide range of degrees of sample hemolysis. This correction would increase diagnostic accuracy, reduce inappropriate therapeutic decisions, and improve patient satisfaction with care.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>27817149</pmid><doi>10.1007/s12026-016-8878-7</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0257-277X
ispartof Immunologic research, 2017-06, Vol.65 (3), p.605-608
issn 0257-277X
1559-0755
language eng
recordid cdi_proquest_miscellaneous_1837025584
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Allergology
Beta cells
Biomedical and Life Sciences
Biomedicine
Diabetes mellitus
Diabetes Mellitus - diagnosis
Diagnostic Errors - prevention & control
Diagnostic systems
Erythrocytes - metabolism
Erythrocytes - pathology
Exposure
Hemolysis
Humans
Hypoglycemia
Hypoglycemia - diagnosis
Immunology
Insulin
Insulin - blood
Insulin resistance
Insulysin
Insulysin - metabolism
Internal Medicine
Medicine/Public Health
Models, Theoretical
Original Article
Precision Medicine
Reproducibility of Results
Serum - metabolism
Statistical analysis
Statistical methods
title Individualized correction of insulin measurement in hemolyzed serum samples
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A25%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Individualized%20correction%20of%20insulin%20measurement%20in%20hemolyzed%20serum%20samples&rft.jtitle=Immunologic%20research&rft.au=Wu,%20Zhi-Qi&rft.date=2017-06-01&rft.volume=65&rft.issue=3&rft.spage=605&rft.epage=608&rft.pages=605-608&rft.issn=0257-277X&rft.eissn=1559-0755&rft_id=info:doi/10.1007/s12026-016-8878-7&rft_dat=%3Cproquest_cross%3E1901185392%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901185392&rft_id=info:pmid/27817149&rfr_iscdi=true